Serzone-5HT2 will go off the market this month in Canada

Serzone-5HT2 will go off the market this month in Canada.

Most, if not all, generic nefazodone products will follow.

So far, Health Canada hasn't mandated this. Nefazodone is associated with liver failure...liver transplants...even death.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote